Infectious DiseasesNCT07048301
Omaha System-Based Health Application on Improving Knowledge, Attitude, and Behaviors Regarding Infectious Disease Prevention in the Community
A study testing BUHOS app in people with Infectious Diseases and Attitude, run by Kocaeli University.
Trial summary
Background: Infectious diseases remain significant public health concerns due to several factors such as climate and environmental changes and natural disasters. Mobile health applications (mHealth apps) can be an appropriate way for fostering community participation, disseminating knowledge, and promoting behavior… Read more about this study
- Who is it for?
- Ages 18 to 64 yearsHealthy volunteers can take part
- Conditions the study is for
- Infectious Diseases, Attitude, Behavior
- What is being tested?
- BUHOS app
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 112 participants
- Where
- No sites listed yet
- Study dates
- Sep 2025to Jun 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 64 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- being aged between 18 and 64 years,
- living in two container cities,
- having a knowledge score of 'very low (1)' and 'low (2)' on the Omaha System Problem Rating Scale for Outcome for Communicable/ Infectious Problem Knowledge Parameter,
- being literate,
- owning a smartphone.
Who cannot join
- having impaired vision or hearing,
- having a mental illness,
- not owning a smartphone,
- being pregnant or postpartum,
- being participants in another scientific study,
- refusing to participate.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
Merve Altıner Yaş, Assistant Professor contact
About this study
Official title: Developing an Omaha System-Based Health Application on Improving Knowledge, Attitude, and Behaviors Regarding Infectious Disease Prevention in the Community
Background: Infectious diseases remain significant public health concerns due to several factors such as climate and environmental changes and natural disasters. Mobile health applications (mHealth apps) can be an appropriate way for fostering community participation, disseminating knowledge, and promoting behavior change toward infectious disease prevention. This study aims to describe a protocol for a pilot randomized controlled study to evaluate the impact of the Omaha System-Based mHealth app (BUHOS) on improving knowledge, attitude, and behaviors (KAB) regarding infectious disease prevention in an earthquake-affected region of Türkiye.
Methods: This study is a two-armed, parallel-group, randomized controlled trial design. A total of 112 eligible participants will be recruited from two separate container cities of an earthquake-affected region. These participants will be randomly allocated to either an intervention group or a control group. BUHOS will be designed based on the Omaha System, a widely recognized standardized taxonomy for the assessment, planning, and evaluation of healthcare services. BUHOS will be a two-week nursing intervention that includes monitoring KAB, employing Education, Guidance and Counseling (education videos), and Surveillance (reminder messages), and assessing the outcomes. Outcome variables will include the Problem Rating Scale for Outcomes, Community Communicable Diseases Knowledge Survey, Communicable Diseases Risk Awareness and Protection Scale and System Usability Scale. Outcome variables will be assessed on the 15th and 30th day after intervention.
Read more
Hypotheses:
H1: Among the Omaha System Problems, the Communicable/ Infectious Condition Problem Knowledge score will be higher on the 15th and 30th days compared to the control group.
H2: Infectious diseases risk awareness and prevention score will be higher on the 15th and 30th days compared to the control group.
H3: Communicable/ Infectious Condition Status Behaviour Parameter score will be higher on the 15th and 30th days compared to the control group H4: The knowledge and behaviour of the communicable/ infectious status and the awareness and prevention of the risk of infectious diseases of the experimental group will be higher than before the intervention on the 15th and 30th days.
- Conditions
- Infectious Diseases, Attitude, Behavior, Knowledge
- Being tested
- BUHOS app, Control Group
- Keywords
- Omaha System, Mobile health app
- Medical subject headings
- Communicable Diseases, Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BUHOS appOther
In this study, the BUHOS app initiative will be implemented among participants in the intervention group. BUHOS will be a two-weeks nursing intervention that includes monitoring KAB, employing Education, Guidance and Counseling (education videos), and Surveillance (reminder messages), and assessing the outcomes.
Control GroupOther
No intervention will be made to the patients in the control group, and the training videos prepared after the study is completed will be shared.
| Study group | Role | What they receive |
|---|---|---|
| BUHOS app | Experimental | BUHOS app Receives: Other: BUHOS app |
| Control Group | Active comparator | Control Group Receives: Other: Control Group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Omaha System- Problem Rating Scale for Outcomes Knowledge parameter
Measured: 15th and 30th day after intervention
Omaha System- Problem Rating Scale for Outcomes Behavior parameter
Measured: 15th and 30th day after intervention
Communicable Diseases Risk Awareness and Protection Scale (CDRAPS)
Measured: 15th and 30th day after intervention
Community Communicable Diseases Knowledge Survey
Measured: 15th and 30th day after intervention
Secondary outcomes (1)
System Usability Scale (SUS)
Measured: 30th day after intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jul 2025
- Study startSep 2025 (estimated)
- Primary completionDec 2025 (estimated)
- Study completionJun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Infectious DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 112 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kocaeli University
- Sponsor type
- University, hospital or other
- Collaborators
- Atlas University, Istanbul Medeniyet University, Istanbul University - Cerrahpasa, Hatay Devlet Hastanesi, Health Institutes of Turkey
- Responsible party
- Principal investigator, Gizemnur Torun, Kocaeli University
- Investigators
- Nesrin İlhan, Assoc. Prof., Principal investigator, Istanbul Medeniyet UniversitySelda Seçginli, Study director, Atlas UniversitySeda Doğru Bolat, Msc., Principal investigator, Hatay State Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07048301
- Sponsor's protocol ID
- 2024-A4-01-39719
- Status last verified
- Jun 2025
- First submitted
- 23 Jun 2025
- Last updated
- 2 Jul 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Secginli S, Altiner Yas M, Torun G, Ilhan N, Dogru Bolat S. Developing an Omaha System-based health application to improve knowledge, attitude, and behaviors regarding infectious disease prevention in the community: a study protocol for a randomized controlled trial. BMC Public Health. 2025 Nov 27;25(1):4170. doi: 10.1186/s12889-025-25587-8.
PubMed 41310526
Study at a glance
From the registry record, last updated by the sponsor on 2 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Developing an Omaha System-Based Health Application on Improving Knowledge, Attitude, and Behaviors Regarding Infectious Disease Prevention in the Community
- ClinicalTrials.gov ID
- NCT07048301
- Acronym / sponsor ID
- 2024-A4-01-39719
- Conditions
- Infectious Diseases, Attitude, Behavior, Knowledge
- Keywords
- Omaha System, Mobile health app
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 112 participants (estimated)
- Lead sponsor
- Kocaeli UniversityUniversity, hospital or other
- Collaborators
- Atlas University, Istanbul Medeniyet University, Istanbul University - Cerrahpasa, Hatay Devlet Hastanesi, Health Institutes of Turkey
- Study start
- Sep 2025 (estimated)
- Primary completion
- Dec 2025 (estimated)
- Study completion
- Jun 2026 (estimated)
- First posted
- 2 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: Infectious diseases remain significant public health concerns due to several factors such as climate and environmental changes and natural disasters. Mobile health applications (mHealth apps) can be an appropriate way for fostering community participation, disseminating knowledge, and promoting behavior change toward infectious disease prevention. This study aims to describe a protocol for a pilot randomized controlled study to evaluate the impact of the Omaha System-Based mHealth app (BUHOS) on improving knowledge, attitude, and behaviors (KAB) regarding infectious disease prevention in an earthquake-affected region of Türkiye.
Methods: This study is a two-armed, parallel-group, randomized controlled trial design. A total of 112 eligible participants will be recruited from two separate container cities of an earthquake-affected region. These participants will be randomly allocated to either an intervention group or a control group. BUHOS will be designed based on the Omaha System, a widely recognized standardized taxonomy for the assessment, planning, and evaluation of healthcare services. BUHOS will be a two-week nursing intervention that includes monitoring KAB, employing Education, Guidance and Counseling (education videos), and Surveillance (reminder messages), and assessing the outcomes. Outcome variables will include the Problem Rating Scale for Outcomes, Community Communicable Diseases Knowledge Survey, Communicable Diseases Risk Awareness and Protection Scale and System Usability Scale. Outcome variables will be assessed on the 15th and 30th day after intervention.
Hypotheses:
H1: Among the Omaha System Problems, the Communicable/ Infectious Condition Problem Knowledge score will be higher on the 15th and 30th days compared to the control group.
H2: Infectious diseases risk awareness and prevention score will be higher on the 15th and 30th days compared to the control group.
H3: Communicable/ Infectious Condition Status Behaviour Parameter score will be higher on the 15th and 30th days compared to the control group H4: The knowledge and behaviour of the communicable/ infectious status and the awareness and prevention of the risk of infectious diseases of the experimental group will be higher than before the intervention on the 15th and 30th days.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| BUHOS app | Experimental | Other: BUHOS appBUHOS app |
| Control Group | Active comparator | Other: Control GroupControl Group |
Who may qualify
- Ages
- 18 to 64 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- being aged between 18 and 64 years,
- living in two container cities,
- having a knowledge score of 'very low (1)' and 'low (2)' on the Omaha System Problem Rating Scale for Outcome for Communicable/ Infectious Problem Knowledge Parameter,
- being literate,
- owning a smartphone.
Key exclusion criteria (6 listed)
- having impaired vision or hearing,
- having a mental illness,
- not owning a smartphone,
- being pregnant or postpartum,
- being participants in another scientific study,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BUHOS appIn this study, the BUHOS app initiative will be implemented among participants in the intervention group. BUHOS will be a two-weeks nursing intervention that includes monitoring KAB, employing Education, Guidance and Counseling (education videos), and Surveillance (reminder messages), and assessing the outcomes. | Other | BUHOS app |
| Control GroupNo intervention will be made to the patients in the control group, and the training videos prepared after the study is completed will be shared. | Other | Control Group |
Primary outcome
Omaha System- Problem Rating Scale for Outcomes Knowledge parameter
Time frame: 15th and 30th day after intervention
Omaha System- Problem Rating Scale for Outcomes Behavior parameter
Time frame: 15th and 30th day after intervention
Communicable Diseases Risk Awareness and Protection Scale (CDRAPS)
Time frame: 15th and 30th day after intervention
Community Communicable Diseases Knowledge Survey
Time frame: 15th and 30th day after intervention
1 secondary outcome
System Usability Scale (SUS)
Time frame: 30th day after intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Jul 2025.
- Derived from this study: PubMed 41310526Secginli S, Altiner Yas M, Torun G, Ilhan N, Dogru Bolat S. Developing an Omaha System-based health application to improve knowledge, attitude, and behaviors regarding infectious disease prevention in the community: a study protocol for a randomized controlled trial. BMC Public Health. 2025 Nov 27;25(1):4170. doi: 10.1186/s12889-025-25587-8.
- Individual participant dataSharing planned: No
Related trials for Infectious Diseases
Not yet recruitingPhase 2
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV)
Active, not recruitingObservational study
Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma
Asymptomatic COVID-19 Infection Laboratory-Confirmed, Symptomatic COVID-19 Infection Laboratory-Confirmed
Active, not recruiting
Evaluating the Effectiveness of a Mobile HIV Prevention App to Increase HIV and Sexually Transmitted Infections (STI) Testing and PrEP Initiation Among Rural Men Who Have Sex With Men
HIV Infections, STI
Active, not recruitingObservational study
Host Response to Infection and Treatment in Filarial Diseases
Filariasis, Helminthiasis
Not yet recruitingPhase 4
Rifaximin for Prevention of Recurrent Mild-to-moderate Ascending Cholangitis After Biliary-enteric Anastomosis
Cholangitis, Ascending Cholangitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Merve Altıner Yaş, Assistant Professor contact
Nesrin İlhan, Assoc. Prof. principal investigator
Istanbul Medeniyet University
Selda Seçginli study director
Atlas University
Seda Doğru Bolat, Msc. principal investigator
Hatay State Hospital
Questions about this trial
What is this clinical trial studying?
A study testing BUHOS app in people with Infectious Diseases and Attitude, run by Kocaeli University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 2 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Gizemnur Torun, PhD. (+902623034722, gizemnur.torun@kocaeli.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Omaha System- Problem Rating Scale for Outcomes Knowledge parameter (time frame: 15th and 30th day after intervention). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07048301, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2025.